KORU Medical Systems (KORU Medical Systems) Total Inventories : $3.15 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is KORU Medical Systems Total Inventories?

KORU Medical Systems's total inventories for the quarter that ended in Mar. 2024 was $3.15 Mil. KORU Medical Systems's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Mar. 2024 was $3.31 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. KORU Medical Systems's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was $0.16.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. KORU Medical Systems's Days Inventory for the three months ended in Mar. 2024 was 97.71.

Inventory Turnover measures how fast the company turns over its inventory within a year. KORU Medical Systems's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.93.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. KORU Medical Systems's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.40.

KORU Medical Systems Total Inventories Historical Data

The historical data trend for KORU Medical Systems's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KORU Medical Systems Total Inventories Chart

KORU Medical Systems Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

2.39

6.83

6.11

6.41

3.48

KORU Medical Systems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Inventories	Get a 7-Day Free Trial															6.64	5.28	4.68	3.48	3.15

KORU Medical Systems Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

KORU Medical Systems (NAS:KRMD) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

KORU Medical Systems's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is

	Net-Net Working Capital Per Share (Q: Mar. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(10.82	+	0.75 * 4.393	+	0.5 * 3.147	-	8.383
-	0	-	0)	/	45.7231
=	0.16

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

KORU Medical Systems's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2024 )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
	=	3.314	/	3.095	*	365 / 4
	=	97.71

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

KORU Medical Systems's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2024 )	/	Average Total Inventories (Q: Mar. 2024 )
	=	3.095	/	3.314
	=	0.93

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

KORU Medical Systems's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	3.314	/	8.198
	=	0.40

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

KORU Medical Systems Total Inventories Related Terms

Thank you for viewing the detailed overview of KORU Medical Systems's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

KORU Medical Systems (KORU Medical Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KORU Medical Systems Inc (NAS:KRMD) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Corporate Drive, Mahwah, NJ, USA, 07430

Website

https://www.korumedical.com

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on home and specialty infusion solutions. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Executives

Manko Joseph M. Jr.	10 percent owner	1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Kenneth E Miller	officer: Chief Commercial Officer	26 MOUNTAINVIEW RD, WARREN NJ 07059
Edward Wholihan	director	C/O ALLENA PHARMACEUTICALS, INC., ONE NEWTOWN EXECUTIVE PARK SUITE 202, NEWTON MA 02462
Linda M Tharby	officer: President and CEO	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Robert Cascella	director	C/O HOLOGIC, INC., BEDFORD MA 01730
Lafrence Andrew D.c.	officer: Chief Financial Officer	C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
Thomas Edward Adams	officer: Interim CFO	524 WOODLAND AVENUE, BRIELLE NJ 08730
Brian Case	officer: Chief Technology Officer	424 CYPRUS CIR, LAKE VILLA IL 60046-8629
Shahriar Matin	director	96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Donna French	director	25 SEARSVILLE COURT, HILLSBOROUGH CA 94010
Donald B Pettigrew	officer: Pres./Chief Commercial Officer	7871 ENGEN LOOP, PARK CITY UT 84098
Karen Fisher	officer: CFO	24 CARPENTER ROAD, CHESTER NY 10918
Daniel S Goldberger	director	24 CARPENTER ROAD, CHESTER NY 10918
R John Fletcher	director	C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
Horton Freedom, L.p.	10 percent owner	1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103